2020

Interferon, the key to many of the worst cases of COVID-19 in young people

An international consortium with the participation of IDIBELL has identified alterations in interferon and the proteins of its signaling pathway, the first line of defense against pathogens, as predictive markers of severity in individuals with no medical history.

Interferon, the key to many of the worst cases of COVID-19 in young people Read More »

IDIBELL participates in Sónar+D to take a trip to the musical brain

A trip into the musical brain: this was the artistic and scientific experience that the 2020 edition of the Sónar+D Festival offered this past Saturday, within a special program that combined the streaming and face-to-face formats from the Center for Contemporary Culture of Barcelona. Dr. Antoni Rodríguez Fornells, a researcher at IDIBELL, ICREA and the

IDIBELL participates in Sónar+D to take a trip to the musical brain Read More »

IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research

The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe. Awarded in the

IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research Read More »

The use of water pipes and passive exposure to their smoke are as harmful as conventional tobacco

Smoking in water pipes and passive exposure to the smoke they produce, increase the risk of lung cancer and other cardiovascular diseases. It is for this reason that its use should be regulated and compliance with the regulations guaranteed.

The use of water pipes and passive exposure to their smoke are as harmful as conventional tobacco Read More »

IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children

The chemoresistance group of IDIBELL and ICO’s ProCURE Program, led by Alberto Villanueva, has transferred its experience in generating orthotopic mouse models in adult patients to the pediatric field.

IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children Read More »

Scroll to Top